|
DE19906744A1
(de)
*
|
1999-02-18 |
2000-08-24 |
Martin Roecken |
Verfahren zur Herstellung antitumoraler Th1-Zellen
|
|
CA2368967A1
(en)
*
|
1999-04-09 |
2000-10-19 |
Biomira, Inc. |
Telomerase-specific cancer vaccine
|
|
DE19917195B4
(de)
|
1999-04-16 |
2006-09-28 |
Immatics Biotechnologies Gmbh |
Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor
|
|
JP2003510094A
(ja)
*
|
1999-09-08 |
2003-03-18 |
トランジェーヌ、ソシエテ、アノニム |
Ｍｕｃ−１由来のペプチド
|
|
GB9921337D0
(en)
*
|
1999-09-09 |
1999-11-10 |
Axis Genetics Plc |
Modified plant viruses
|
|
GB0007150D0
(en)
*
|
2000-03-24 |
2000-05-17 |
Lamellar Therapeutics Limited |
Immunotherapeutic methods and compositions
|
|
ES2424131T3
(es)
*
|
2001-03-27 |
2013-09-27 |
Oncothyreon Inc. |
Vacuna para modular respuestas inmunitarias entre T1 y T2
|
|
IL164079A0
(en)
|
2002-03-15 |
2005-12-18 |
Us Dept Veterans Affairs |
Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
|
|
WO2003089574A2
(en)
*
|
2002-04-15 |
2003-10-30 |
Biomira, Inc. |
Synthetic glyco-lipo-peptides as vaccines
|
|
EP1537143A2
(en)
*
|
2002-09-05 |
2005-06-08 |
Cell Center Cologne GmbH |
Immunogenic muc1 glycopeptides
|
|
KR20050062605A
(ko)
*
|
2002-10-10 |
2005-06-23 |
디파트먼트 오브 베테랑스 어페어스 오피스 오브 더 제네럴 카운셀 (024) |
종양 특이적 에피토프에 대해 지정된 표지된 활성화임파구를 이용한 종양의 검출, 위치결정 및 병기결정
|
|
US20050045205A1
(en)
*
|
2003-08-29 |
2005-03-03 |
Stach Steven R. |
Apparatus and method for cleaning printed circuit boards
|
|
GB0322448D0
(en)
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
|
JP5060134B2
(ja)
|
2003-12-12 |
2012-10-31 |
ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
ヒト細胞傷害性Ｔリンパ球のエピトープ及びそのＭＵＣ−１の非ＶＮＴＲ（ｎｏｎ−ｖａｒｉａｂｌｅｎｕｍｂｅｒｏｆｔａｎｄｅｍｒｅｐｅａｔｓｅｑｕｅｎｃｅ）由来のアゴニストエピトープ
|
|
TW201204410A
(en)
|
2004-04-01 |
2012-02-01 |
Oncothyreon Inc |
Mucinous glycoprotein (MUC-1) vaccine
|
|
EP1812052A1
(en)
*
|
2004-11-02 |
2007-08-01 |
Biomedical Research Models, Inc. |
Methods of cancer treatment/prevention using cancer cell-specific surface antigens
|
|
PL1896051T3
(pl)
|
2005-06-28 |
2015-04-30 |
Oncothyreon Inc |
Sposób leczenia pacjentów szczepionką glikoproteiny mucynowej (muc-1)
|
|
WO2010002478A2
(en)
|
2008-07-03 |
2010-01-07 |
University Of Georgia Research Foundation, Inc. |
Glycopeptide and uses thereof
|
|
EP1989326A4
(en)
|
2006-01-17 |
2009-09-30 |
Health Research Inc |
BIO-HETERODUPLEX TRACKING TEST
|
|
RU2377994C1
(ru)
*
|
2008-05-21 |
2010-01-10 |
Леонид Валентинович Загребин |
Способ иммунореабилитации онкозаболеваний
|
|
WO2010030505A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Austin American Technology Corporation |
Cleaning and testing ionic cleanliness of electronic assemblies
|
|
AU2011226992B2
(en)
|
2010-05-10 |
2012-03-22 |
Ascend Biopharmaceuticals Pty Ltd |
Immunostimulatory and vaccine compositions
|
|
KR20140023903A
(ko)
|
2011-02-24 |
2014-02-27 |
온코타이레온, 인코포레이티드 |
항원보강제를 갖는 muc1 기초 당지질펩티드 백신
|
|
EP2800762B1
(en)
|
2012-01-03 |
2018-01-03 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Native and agonist ctl epitopes of the muc1 tumor antigen
|
|
CN105283199A
(zh)
|
2013-05-14 |
2016-01-27 |
默克专利股份公司 |
通过muc-1脂肽接种治疗肺癌的方法
|
|
WO2015058831A1
(en)
|
2013-10-25 |
2015-04-30 |
Merck Patent Gmbh |
Elevated biomarker expression in lung cancer patients responding to treatment with muc-1 lipopeptide vaccines
|
|
CN116970059A
(zh)
|
2016-12-22 |
2023-10-31 |
库尔生物制药有限公司 |
T细胞调节性多聚体多肽及其使用方法
|
|
US11851471B2
(en)
|
2017-01-09 |
2023-12-26 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
IL269000B2
(en)
|
2017-03-15 |
2024-06-01 |
Cue Biopharma Inc |
Methods for modulating an immune response
|
|
GB201812647D0
(en)
|
2018-08-03 |
2018-09-19 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Viral vectors and methods for the prevention or treatment of cancer
|
|
JP2022536581A
(ja)
*
|
2019-06-19 |
2022-08-18 |
キュー バイオファーマ， インコーポレイテッド |
多量体ｔ細胞調節性ポリペプチド及びその使用方法
|
|
TW202208395A
(zh)
|
2020-05-12 |
2022-03-01 |
美商信號生物製藥公司 |
多聚體ｔ細胞調節多肽及其使用方法
|
|
EP4211149A4
(en)
|
2020-09-09 |
2024-10-09 |
Cue Biopharma, Inc. |
MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
|